GMP ORPHAN DRUGS FOR ORPHAN DISEASES Trademark

Trademark Overview


On Tuesday, May 14, 2013, a trademark application was filed for GMP ORPHAN DRUGS FOR ORPHAN DISEASES with the United States Patent and Trademark Office. The USPTO has given the GMP ORPHAN DRUGS FOR ORPHAN DISEASES trademark a serial number of 79134010. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Saturday, February 6, 2021. This trademark is owned by GMP-ORPHAN. The GMP ORPHAN DRUGS FOR ORPHAN DISEASES trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical and veterinary products for the treatment of orphan diseases; medication for the treatment of orphan diseases; pharmaceutical and veterinary products for pediatric use for the treatment of orphan diseases; medication for pediatric use for the treatment of orphan diseases; chemical preparations for medical or pharmaceutical use in the treatment of childhood diseases; pharmaceutical and veterinary products and medicines for the treatment of orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy; pharmaceutical and veterinary products and medicines for the treatment of hyperammonemia of all kinds

Medical services; medical and sanitary care, namely, telemedecine services including remote diagnosis or medical follow-up; medical testing for the diagnosis and treatment of persons; providing medical advice on health matters in the field of medication administration; providing medical advisory services relating to medical apparatus and instruments; medical diagnosis services of orphan diseases; providing medical information, all the aforesaid services in connection with the treatment of childhood and orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy

[ Medical, surgical and veterinary apparatus and instruments, for diagnosis and treatment, particularly in connection with orphan diseases; medical devices containing chemical products for diagnostic use of orphan diseases; medical diagnosis apparatus and instruments to diagnose orphan diseases; automatic testing apparatus to diagnose orphan diseases, for medical use, also in the form of kits; medical apparatus and instruments in the form of kits for detecting the presence of analytes in biological fluids, other fluids and other structures; immunochemical testing apparatus for medical use; blood testing apparatus; radiological apparatus for medical use; resuscitation apparatus; medical imaging apparatus incorporating medical imaging software; needles for medical use; gloves for medical use; syringes for medical use; inhalers for medical purposes; injectors for medical use; X-ray photographs for medical use; radiology screens for medical use; receptacles for applying medicines; containe...

Evaluations, assessments and research in the fields of science; research and development services in the field of medicine; research and development of new products for others, namely, medical diagnosis apparatus; research and development in the field of biotechnology; scientific research for medical purposes; scientific laboratory services in the medical field; all the aforesaid services in connection with the treatment of childhood and orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy
gmp orphan drugs for orphan diseases

General Information


Serial Number79134010
Word MarkGMP ORPHAN DRUGS FOR ORPHAN DISEASES
Filing DateTuesday, May 14, 2013
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateSaturday, February 6, 2021
Registration Number4541221
Registration DateTuesday, June 3, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 18, 2014

Trademark Statements


Description of MarkThe mark consists of the literal stylized wording "gmp orphan drugs for orphan diseases". The wording "gmp" and "drugs for orphan diseases" appear in the color white, and the wording "orphan" is in black. The wording "gmp" is displayed with the letter "o" of the wording "orphan" above the wording "drugs for orphan diseases" all in a blue box, and the letters "rphan" appear outside of the box.
Goods and ServicesPharmaceutical and veterinary products for the treatment of orphan diseases; medication for the treatment of orphan diseases; pharmaceutical and veterinary products for pediatric use for the treatment of orphan diseases; medication for pediatric use for the treatment of orphan diseases; chemical preparations for medical or pharmaceutical use in the treatment of childhood diseases; pharmaceutical and veterinary products and medicines for the treatment of orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy; pharmaceutical and veterinary products and medicines for the treatment of hyperammonemia of all kinds
Indication of Colors claimedThe color(s) white, blue and black is/are claimed as a feature of the mark.
Goods and ServicesMedical services; medical and sanitary care, namely, telemedecine services including remote diagnosis or medical follow-up; medical testing for the diagnosis and treatment of persons; providing medical advice on health matters in the field of medication administration; providing medical advisory services relating to medical apparatus and instruments; medical diagnosis services of orphan diseases; providing medical information, all the aforesaid services in connection with the treatment of childhood and orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy
Goods and Services[ Medical, surgical and veterinary apparatus and instruments, for diagnosis and treatment, particularly in connection with orphan diseases; medical devices containing chemical products for diagnostic use of orphan diseases; medical diagnosis apparatus and instruments to diagnose orphan diseases; automatic testing apparatus to diagnose orphan diseases, for medical use, also in the form of kits; medical apparatus and instruments in the form of kits for detecting the presence of analytes in biological fluids, other fluids and other structures; immunochemical testing apparatus for medical use; blood testing apparatus; radiological apparatus for medical use; resuscitation apparatus; medical imaging apparatus incorporating medical imaging software; needles for medical use; gloves for medical use; syringes for medical use; inhalers for medical purposes; injectors for medical use; X-ray photographs for medical use; radiology screens for medical use; receptacles for applying medicines; containers especially made for medical waste; probes for medical use; stethoscopes; heart pacemakers; thermometers for medical use; cases fitted for medical instruments for use by surgeons or doctors ]
Disclaimer with Predetermined Text"ORPHAN" AND "DRUGS FOR ORPHAN DISEASES"
Goods and ServicesEvaluations, assessments and research in the fields of science; research and development services in the field of medicine; research and development of new products for others, namely, medical diagnosis apparatus; research and development in the field of biotechnology; scientific research for medical purposes; scientific laboratory services in the medical field; all the aforesaid services in connection with the treatment of childhood and orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 12, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeG - NOT AVAILABLE
Class Status DateSaturday, February 6, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 12, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 12, 2013
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameORPHALAN
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameGMP-ORPHAN
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameGMP-ORPHAN
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Friday, June 9, 2023INTERNATIONAL REGISTRATION RENEWED
Saturday, June 3, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sunday, December 5, 2021PARTIAL INVALIDATION PROCESSED BY THE IB
Wednesday, October 27, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, October 27, 2021INVALIDATION PROCESSED
Wednesday, October 6, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, February 6, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Saturday, February 6, 2021REGISTERED - PARTIAL SEC 71 ACCEPTED
Monday, February 1, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 29, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, December 3, 2020TEAS SECTION 71 RECEIVED
Monday, June 3, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, February 7, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 8, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, March 3, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 21, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 21, 2014FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 21, 2014FINAL DISPOSITION PROCESSED
Wednesday, September 3, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 3, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, March 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 18, 2014PUBLISHED FOR OPPOSITION
Friday, March 14, 2014NOTIFICATION PROCESSED BY IB
Wednesday, February 26, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 26, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 7, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 5, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 5, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 5, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 30, 2014ASSIGNED TO LIE
Wednesday, January 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 30, 2013REFUSAL PROCESSED BY IB
Wednesday, September 11, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 11, 2013REFUSAL PROCESSED BY MPU
Wednesday, September 11, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 10, 2013NON-FINAL ACTION WRITTEN
Tuesday, September 3, 2013ASSIGNED TO EXAMINER
Friday, August 16, 2013APPLICATION FILING RECEIPT MAILED
Monday, August 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 8, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB